Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf055 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Rachel D Harris und 24 weiteren Autor:innen. Beteiligte Einrichtung: Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Methotrexate, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neurotoxicity Syndromes, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Methotrexate is a critical component of pediatric acute lymphoblastic leukemia (ALL) therapy that can result in neurotoxicity which has been associated with an increased risk of relapse. We leveraged machine learning to develop a neurotoxicity risk prediction model in a diverse cohort of children with ALL.
Methods
We included children (age 2-20 years) diagnosed with ALL (2005-2019) and treated in Texas without pre-existing neurologic disease. Clinical information was obtained by medical record review. Neurotoxicity occurring post-induction and prior to maintenance therapy was defined as neurologic episodes occurring within 21 days of methotrexate. Suspected cases were independently confirmed by 2 pediatric oncologists. Demographic and clinical factors were compared using logistic regression. The dataset was randomly split (80/20) for training and testing. random forest (RF) with boosting and downsampling using 5-repeat, 10-fold cross-validation was used to construct a predictive model.
Results
Neurotoxicity developed in 115 (8.7%) of 1325 eligible patients. Several factors including older age at diagnosis (OR = 1.19, 95% CI: 1.15-1.24) and Latino ethnicity (OR = 2.79, 95% CI: 1.83-4.35) were associated with neurotoxicity. The RF had an area under the curve of 0.77 with a train error rate of 0.29 and a test error rate of 0.24. The overall sensitivity was 0.73, and specificity was 0.69.
Conclusions
In one of the largest studies of its kind, we developed a novel risk prediction model of methotrexate-related neurotoxicity. Ultimately, a validated model may help guide the development of personalized treatment strategies to reduce the burden of neurotoxicity in children diagnosed with ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.
- Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
- Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA.
- Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA.
- Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Deparment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
ORCID-Profile: Han Chen, Austin L Brown
Förderung
- NCI NIH HHS
Zitieren
APA
Harris, R. D., Taylor, O. A., Gramatges, M. M., Hughes, A. E., Zobeck, M., Pruitt, S., Bernhardt, M. B., Chavana, A., Huynh, V., Ludwig, K., Klesse, L., Heym, K., Griffin, T., Erana, R., Bernini, J. C., Choi, A., Ohno, Y., Richard, M. A., Morrison, A. C., …, & Brown, A. L. (2025). Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. The Oncologist. https://doi.org/10.1093/oncolo/oyaf055
Vancouver
Harris RD, Taylor OA, Gramatges MM, Hughes AE, Zobeck M, Pruitt S, et al. Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. The Oncologist. 2025. doi:10.1093/oncolo/oyaf055
BibTeX
@article{Harris2025,
author = {Harris, Rachel D and Taylor, Olga A and Gramatges, Maria Monica and Hughes, Amy E and Zobeck, Mark and Pruitt, Sandi and Bernhardt, M Brooke and Chavana, Ashley and Huynh, Van and Ludwig, Kathleen and Klesse, Laura and Heym, Kenneth and Griffin, Timothy and Erana, Rodrigo and Bernini, Juan Carlos and Choi, Ashley and Ohno, Yuu and Richard, Melissa A and Morrison, Alanna C and Chen, Han and Yu, Bing and Lupo, Philip J and Rabin, Karen R and Scheurer, Michael E and Brown, Austin L},
title = {Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf055}
}
EUVIMED